EA201300358A1 - MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITE - Google Patents

MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITE

Info

Publication number
EA201300358A1
EA201300358A1 EA201300358A EA201300358A EA201300358A1 EA 201300358 A1 EA201300358 A1 EA 201300358A1 EA 201300358 A EA201300358 A EA 201300358A EA 201300358 A EA201300358 A EA 201300358A EA 201300358 A1 EA201300358 A1 EA 201300358A1
Authority
EA
Eurasian Patent Office
Prior art keywords
zeolite
naphthalan
refined
treatment
inflammatory diseases
Prior art date
Application number
EA201300358A
Other languages
Russian (ru)
Other versions
EA021871B1 (en
Inventor
Алишир Вейс оглы Мусаев
Тамилла Ширин кызы Халилова
Халида Тофик кызы Кахраманова
Original Assignee
Тамилла Ширин кызы Халилова
Халида Тофик кызы Кахраманова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тамилла Ширин кызы Халилова, Халида Тофик кызы Кахраманова filed Critical Тамилла Ширин кызы Халилова
Priority to EA201300358A priority Critical patent/EA021871B1/en
Publication of EA201300358A1 publication Critical patent/EA201300358A1/en
Publication of EA021871B1 publication Critical patent/EA021871B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к созданию средства для лечения воспалительных заболеваний опорно-двигательного аппарата на основе рафинированной нефти (нафталана) и цеолита (клиноптилолита). Как средства для лечения заболеваний опорно-двигательного аппарата известны препараты на основе как нафталана, так и цеолита (каждый в отдельности) и используются издавна. Предлагаемое средство содержит: цеолит - 18-25; парафин+воск - 1:1-16-20; морская соль - 3-5; Ag-цеолит - 1-3; рафинированный нафталан - остальное. Сущность предлагаемого изобретения заключается в том, что лекарственные композиции для локального лечения воспалительных заболеваний как суставов и мышц, так и эпидермиса путем введения в заявляемых пределах в состав новых ингредиентов, их количественное соотношение обеспечивают активацию обменных процессов в коже, нормализуют кровоснабжение, ликвидируют застойные явления в зонах воспаления, ускоряют проникновение активных лечебных веществ в пораженные участки, при этом не вызывают аллергического фона.The invention relates to the creation of tools for the treatment of inflammatory diseases of the musculoskeletal system based on refined oil (naphthalan) and zeolite (clinoptilolite). As agents for the treatment of diseases of the musculoskeletal system, preparations based on both naphthalan and zeolite (individually) are known and have been used for a long time. The proposed tool contains: zeolite - 18-25; paraffin wax + 1: 1-16-20; sea salt - 3-5; Ag zeolite 1-3; refined naphthalan - the rest. The essence of the invention lies in the fact that medicinal compositions for the local treatment of inflammatory diseases of both joints and muscles and the epidermis by introducing new ingredients into the claimed limits, their quantitative ratio ensures the activation of metabolic processes in the skin, normalizes blood supply, eliminates stagnation areas of inflammation, accelerate the penetration of active therapeutic substances in the affected areas, while not causing an allergic background.

EA201300358A 2012-05-10 2012-05-10 Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite EA021871B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201300358A EA021871B1 (en) 2012-05-10 2012-05-10 Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201300358A EA021871B1 (en) 2012-05-10 2012-05-10 Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite

Publications (2)

Publication Number Publication Date
EA201300358A1 true EA201300358A1 (en) 2013-11-29
EA021871B1 EA021871B1 (en) 2015-09-30

Family

ID=49684442

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300358A EA021871B1 (en) 2012-05-10 2012-05-10 Medication for treatment of locomotor system disorders based on refined naphthalan mixed with zeolite

Country Status (1)

Country Link
EA (1) EA021871B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2702628C1 (en) * 2019-03-05 2019-10-09 Общество с ограниченной ответственностью "АрБиПи" Balneological concentrate composition containing oil of naphthalan refined

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2113855C1 (en) * 1995-03-01 1998-06-27 Андрей Эдуардович Тараканов Biologically-active local antiinflammatory and antidegenetarive-dystrophic dough, method of its preparation, species of medicinal plants for it, and method for treatment of inflammatory, denerative-dystrophic diseases of locomotor system
RU2238099C1 (en) * 2003-06-18 2004-10-20 Общество с ограниченной ответственностью "Цамакс" Medicinal agent for treatment of diseases of locomotor system
RU2416415C1 (en) * 2010-02-08 2011-04-20 Общество с ограниченной ответственностью "СОЗИДАТЕЛЪ" Calcium salt agent for treating locomotive diseases in human and animals, including bone fractures and diseases associated with calcium deficiency

Also Published As

Publication number Publication date
EA021871B1 (en) 2015-09-30

Similar Documents

Publication Publication Date Title
CL2017002767A1 (en) New specific proteins for cd137.
PH12016502254A1 (en) Keratin treatment formulations and methods
EA201790195A1 (en) METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS
BR112015006828A8 (en) compound, or a pharmaceutically acceptable salt thereof; pharmaceutical composition; use of the compound; and method for modulating the activity of an ire1 protein
MX2017010697A (en) Mixed allergen compositions and methods for using the same.
BR112014008700A2 (en) compositions useful in the treatment of nephropathy and processes for preparing same
PE20180399A1 (en) TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE OF THE SAME
CL2021000207A1 (en) New fusion proteins specific for cd137 and pd-l1
EA201390826A1 (en) PYRIMIDINOUS CONNECTIONS FOR USE IN TREATING DISEASES OR STATES MEDIATED BY Lp-PLA
FR3034993B1 (en) UNIT PACKAGING, COMPOSITIONS AND THERAPEUTIC DIAGRAMS FOR THE ADMINISTRATION OF PRO-RESOLUTION PATHWAY STIMULATORS ON KERATINIC SURFACES
BR112017026535A2 (en) compound of formula I, isolated enantiomer, pharmaceutical composition, method for inhibiting mct4 monocarboxylate transporter activity, method for selectively inhibiting mct4 monocarboxylate transporter activity, method for treating a mct4 monocarboxylate transporter mediated disorder and use of a compound
BR112019017393A8 (en) Pharmaceutical composition of evolocumab and its use, kit, method for preparing pcsk9-binding polypeptide and method for formulating therapeutic polypeptide
AR094851A1 (en) BICYCLIC COMPOUNDS AS S1P₁ AGONISTS
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
BR112013011064A2 (en) nutraceutical or oral cosmetic use and oral cosmetic treatment process
UA112418C2 (en) THERAPEUTIC DISEASE
EA201300358A1 (en) MEANS FOR TREATING THE SUPPORT-MOTOR APPARATUS ON THE BASIS OF THE REFINED NAFTALAN IN MIXTURE WITH ZEOLITE
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
BR112022003639A8 (en) BIO-STIMULATING AGENT FOR TREATMENT OF PLANTS AND/OR PLANT SEEDS
BR112015022025A8 (en) composition and use of an active agent
MX2015008676A (en) Metadichol r liquid and gel nanoparticle formulations.
BR112016028561A2 (en) composition, dosage form, and methods for reducing the risk for mortality in an individual, the risk for a disease or condition in an individual, triglycerides in an individual's blood, an individual's resting heart rate, lipoprotein cholesterol non-high density in an individual, total cholesterol in an individual, apolipoprotein b in an individual blood, systolic blood pressure in an individual, and diastolic blood pressure in an individual, to prolong an individual's life, to treat hypertriglyceridemia in an individual and to increase an omega-3 index in an individual's red blood cells.
EA201400703A1 (en) MEDICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PSORIASIS
WO2023041524A3 (en) Compositions and methods for treating synucleinopathies
EA202092554A1 (en) COMPOSITIONS FOR TREATMENT OF SKIN DISEASES

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU